US economy

FDA panel recommending approval of first peanut allergy treatment for kids


An estimated 1.6 million children and teenagers would be eligible for the medication, to be sold as Palforzia, an intended for ages 4 to 17.

      



READ SOURCE

Leave a Reply

This website uses cookies. By continuing to use this site, you accept our use of cookies.